Suppr超能文献

S6激酶的受体结合与酪氨酸磷酸化

Receptor association and tyrosine phosphorylation of S6 kinases.

作者信息

Rebholz Heike, Panasyuk Ganna, Fenton Timothy, Nemazanyy Ivan, Valovka Taras, Flajolet Marc, Ronnstrand Lars, Stephens Len, West Andrew, Gout Ivan T

机构信息

Ludwig Institute for Cancer Research, London, UK.

出版信息

FEBS J. 2006 May;273(9):2023-36. doi: 10.1111/j.1742-4658.2006.05219.x.

Abstract

Ribosomal protein S6 kinase (S6K) is activated by an array of mitogenic stimuli and is a key player in the regulation of cell growth. The activation process of S6 kinase involves a complex and sequential series of multiple Ser/Thr phosphorylations and is mainly mediated via phosphatidylinositol 3-kinase (PI3K)-3-phosphoinositide-dependent protein kinase-1 (PDK1) and mTor-dependent pathways. Upstream regulators of S6K, such as PDK1 and protein kinase B (PKB/Akt), are recruited to the membrane via their pleckstrin homology (PH) or protein-protein interaction domains. However, the mechanism of integration of S6K into a multi-enzyme complex around activated receptor tyrosine kinases is not clear. In the present study, we describe a specific interaction between S6K with receptor tyrosine kinases, such as platelet-derived growth factor receptor (PDGFR). The interaction with PDGFR is mediated via the kinase or the kinase extension domain of S6K. Complex formation is inducible by growth factors and leads to S6K tyrosine phosphorylation. Using PDGFR mutants, we have shown that the phosphorylation is exerted via a PDGFR-src pathway. Furthermore, src kinase phosphorylates and coimmunoprecipitates with S6K in vivo. Inhibitors towards tyrosine kinases, such as genistein and PP1, or src-specific SU6656, but not PI3K and mTor inhibitors, lead to a reduction in tyrosine phosphorylation of S6K. In addition, we mapped the sites of tyrosine phosphorylation in S6K1 and S6K2 to Y39 and Y45, respectively. Mutational and immunofluorescent analysis indicated that phosphorylation of S6Ks at these sites does not affect their activity or subcellular localization. Our data indicate that S6 kinase is recruited into a complex with RTKs and src and becomes phosphorylated on tyrosine/s in response to PDGF or serum.

摘要

核糖体蛋白S6激酶(S6K)可被一系列促有丝分裂刺激激活,是细胞生长调控中的关键因子。S6激酶的激活过程涉及一系列复杂且有序的多个丝氨酸/苏氨酸磷酸化反应,主要通过磷脂酰肌醇3激酶(PI3K)-3-磷酸肌醇依赖性蛋白激酶-1(PDK1)和mTor依赖性途径介导。S6K的上游调节因子,如PDK1和蛋白激酶B(PKB/Akt),通过其普列克底物蛋白同源(PH)结构域或蛋白质-蛋白质相互作用结构域被招募到细胞膜。然而,S6K整合到活化受体酪氨酸激酶周围的多酶复合物中的机制尚不清楚。在本研究中,我们描述了S6K与受体酪氨酸激酶(如血小板衍生生长因子受体(PDGFR))之间的特异性相互作用。与PDGFR的相互作用是通过S6K的激酶结构域或激酶延伸结构域介导的。复合物的形成可被生长因子诱导,并导致S6K酪氨酸磷酸化。使用PDGFR突变体,我们表明磷酸化是通过PDGFR-src途径进行的。此外,src激酶在体内使S6K磷酸化并与S6K进行共免疫沉淀。酪氨酸激酶抑制剂,如染料木黄酮和PP1,或src特异性抑制剂SU6656,但不是PI3K和mTor抑制剂,会导致S6K酪氨酸磷酸化减少。此外,我们将S6K1和S6K2中的酪氨酸磷酸化位点分别定位到Y39和Y45。突变和免疫荧光分析表明,S6K在这些位点的磷酸化不影响其活性或亚细胞定位。我们的数据表明,S6激酶被招募到与受体酪氨酸激酶和src的复合物中,并在响应血小板衍生生长因子(PDGF)或血清时在酪氨酸位点发生磷酸化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验